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LELI FOR ACUTE STROKE 
Jackson Streeter, PhotoThera, Inc. USA 
• One stroke every 45 sec in NA 
• 1.8 million new strokes per year in industrialized 
• One FDA approved TX is TPa 
Strokes: 
• 85% ischemia 
• 15% hemorrhagic: 50 % die within 3 hours 
• Time is the critical element of stroke TX 
o Tpa can only be used w/I 3 hours or make worse 
Technology 
• Laser through skull to cortex,  
• Absorbed by mitochondria, (not removing clot) which increases 
mitochondrial viability and activity,  
• Stimulates over 100 metabolic reactions (increase ATP, neurotransmitters, 
decrease apaptosis 
• Results in neuroprotection 
Human studies 
STAIR (stroke therapy academic and industry roundtable) Criteria 
• Appropriate animal models 
• Functional tests more important than imaging 
• External lab validation 
• “Exposure” 
• Time window 
Their additional criteria: 
• Effective in human neurons in vitro 
• Able to deliver required amount of energy in man 
• Work in a clot model (rabbit clot model) 
Rabbit MCA Occlusion: filament threaded to block MCA, inducing and infarct 
• Can delay TX up to 24 hours and still show efficacy 
• 808 nm, 10 mW/cm 2, 1.2 joules 
• See efficacy at 2, 3, 4 wks after a single treatment, significant at p<0.0001 
Questions: 
• Hemorrhagic stroke? Have shown benefit in 6 animals 
 
Need 150 joules to get warming and increased blood flow. 
 
